Grodziskie Zakłady Farmaceutyczne Polfa sp. z o.o., a member of the Gedeon Richter Group, is one of the leading and most experienced pharmaceutical companies in Poland. Polfa was a pioneer in the production of drugs and chemical substances and its beginnings go back to the end the 19thcentury.
Polfa Grodzisk medicines, which incorporate the latest achievements of chemistry, technology and engineering, are of the highest quality. The company specialises in the production of drugs for people, which are classified into several therapeutic groups. The most important of them include cardiac, antimyoctic and immunostimulating drugs. The production is carried out in compliance with GMP (Good Manufacturing Practice) requirements, which means that the products are manufactured in strictly controlled conditions, with every stage of production being regulated by precise procedures.
Polfa Grodzisk invests in research and attaches great importance to the development of medical and pharmaceutical sciences in Poland. Every year, the company, which acts in the area of generic drugs, invents new molecules with a view of lengthening the human lifespan and improving the quality of life. Research is conducted in a modern and well-equipped laboratory complex. Polfa Grodzisk cooperates with numerous scientific organisations, such as the Pharmaceutical Institute, The Foundation for the Development of Warsaw Pharmaceutical Faculty and Polish Veterinary Association.
The renown trademark and successes of Grodziskie Zakłady Farmaceutyczne “Polfa” Sp. z o.o. are, first of all, the effects of the work of highly qualified specialists, the authors of 847 invention projects and 39 technological patents, the winners of 12 awards and prizes granted for product quality and innovation.
